Novel Dispersible Tablet Composition

Patent No. EP1906937 (titled "Novel Dispersible Tablet Composition") was filed by Rubicon Research Private on Jul 24, 2006. The application was issued on Oct 19, 2016.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
TILLOTTS PHARMA AGJul 19, 2017BECK GREENER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP1906937

RUBICON RESEARCH PRIVATE
Application Number
EP06842712A
Filing Date
Jul 24, 2006
Status
Revoked
Jun 4, 2021
Publication Date
Oct 19, 2016